ArticleThe journal of headache and pain2022

Galcanezumab effect on "whole pain burden" and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience.

Marcello Silvestro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.